Gastrointestinal Cancer, Nonmalignant Disease, Palliative Care

Speaker: Chen Wang, MD - Department of Radiation Oncology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing

02:30pm - 03:45pm PT

MRI-Simulator and MR-Linac in Esophageal and Gastric Cancers: An Imaging-Pathology Correlation Study

Speaker: Su Chen Fong, MBBS - Peter MacCallum Cancer Centre, Melbourne

02:30pm - 03:45pm PT

Multivariate Analysis of Outcomes of Palliative Radiotherapy and Re-Irradiation in Children

Speaker: Faisal Habbab, MBBS - Cross Cancer Institute, Edmonton

02:30pm - 03:45pm PT

Neo-Adjuvant Radiotherapy Induced Pelvic Bone Marrow FDG PET Uptake Difference to Predict Chemotherapy Related Hematologic Toxicity in Rectal Cancer Patients

Speaker: Gulsah Ozden, MD - Marmara University, Istanbul

02:30pm - 03:45pm PT

Neoadjuvant Therapy Approaches for Resectable Locally Advanced Esophageal Squamous Cell Carcinoma: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials

Speaker: Chia Ching Lee, MD - National University Cancer Institute Singapore, Singapore

02:30pm - 03:45pm PT

Neuroanatomical Synergy in Cyberknife Stereotactic Ablative Neuromodulation: Revisiting Contouring Paradigms with Dopamine PET-CT and Fgatir MRI for Ventral Intermediate Nucleus Targeting in Parkinson's Disease for Improved Outcomes — A Subcontinental Fir

Speaker: G Lohith, MD - HCG,

02:30pm - 03:45pm PT

Neuropsychological Screening, Advance Care Planning, and End-of-Life Care among Vulnerable Older Adults Undergoing Stereotactic Body Radiotherapy for Early-Stage Non-Small Cell Lung Cancer

Speaker: Leah Thompson, MD - Harvard Radiation Oncology Program, Boston

02:30pm - 03:45pm PT

Neurostructural Paradox in Trigeminal Neuralgia: VBM Reveals Pain Network Remodeling after Radiosurgery

Speaker: Vangipuram Shankar, MD, MBBS - Apollo Proton Cancer Centre, Chennai

02:30pm - 03:45pm PT

Non-Surgical Management of Rectal Adenocarcinoma in a Safety-Net Hospital System: Outcomes and Implications for Watch and Wait Strategies

Speaker: Ashley Chavana, BS - Baylor College of Medicine, Houston

02:30pm - 03:45pm PT

Oncological Outcomes of Dose-Escalated Chemoradiotherapy vs. Total Neoadjuvant Therapy in Locally Advanced Rectal Cancer: A Retrospective Analysis

Speaker: Abdullah Alswilem, MBBS - King Saud University Medical City, Riyadh

02:30pm - 03:45pm PT

Opioid-Related Hospitalizations and Benzodiazepine Co-Prescription in Older Cancer Survivors

Speaker: Sakshith Reddy Chintala, MS - University of California San Diego Health, San Diego

02:30pm - 03:45pm PT

Optimization of Radiotherapy Modality in Elderly Esophageal Cancer Patients: A Decade-Long Retrospective Survival Analysis

Speaker: Yan Luo, PhD - Radiation Oncology Center, Chongqing University Cancer Hospital, Chongqing

02:30pm - 03:45pm PT

Optimizing Palliative Radiotherapy: Analysis of Workflow and Efficiency of a Dedicated Rapid-Access Palliative and Oligometastatic Radiotherapy Program

Speaker: Amiya Agrawal, MD, MBBS - Tata Memorial Hospital, Mumbai

02:30pm - 03:45pm PT

Organ Preservation in Locally Advanced Rectal Cancer Treated with Contact X-Ray Brachytherapy: A Systematic Review and Single-Arm Meta-Analysis

Speaker: Adriana Dominguez Ayala, MD - ISSSTE, Mexico City

02:30pm - 03:45pm PT

Outcomes in Borderline Resectable Pancreatic Cancer: Impact of Integrated Pathologic Score

Speaker: Torrin Jacobsen, MS, BS - Lake Erie College of Osteopathic Medicine Bradenton, Tampa

02:30pm - 03:45pm PT

Outcomes of Extensive-Stage Small-Cell Esophagus Cancer Patients Treated with Different Treatment Modalities: A Multi-Institutional Retrospective Analysis

Speaker: Wei Huang, PhD - Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, jinan

02:30pm - 03:45pm PT

Outcomes of Re-Irradiation with Pencil Beam Scanning Proton Therapy for Rectal Cancer Following Prior Pelvic Radiation: Toxicity, Recurrence, and Symptom Improvement

Speaker: Austin Thompson, MD - University of Maryland Medical Center, Baltimore

02:30pm - 03:45pm PT

Pain Response to Palliative Radiation Therapy in Korean American Cancer Patients with Metastases to Bone

Speaker: Iris Kang, BS - Keck School of Medicine of USC, Los Angeles

02:30pm - 03:45pm PT

Palliative Radiotherapy within the Last 30 Days of Life: A Multi-Site Review of Practice Patterns

Speaker: Van Handke, EMT - MD Anderson Cancer Center, Houston

02:30pm - 03:45pm PT

Pancreatic Reirradiation: A Multi-Institutional Retrospective Analysis of Feasibility, Tolerability and Clinical Outcomes

Speaker: Helen Hou, - Massachusetts General Hospital, Boston

02:30pm - 03:45pm PT

Perioperative Radiation Therapy for Prevention of Recurrent Arthrofibrosis after Revision Total Knee Arthroplasty

Speaker: Jason Liu, BS - UCF College of Medicine, Orlando

02:30pm - 03:45pm PT

Phase II Trial of Autologous Lymphocyte Infusions after Radiotherapy to Mitigate Radiation Induced Lymphopenia and Enhance Immune Reconstitution in Patients with Solid Tumor Malignancies

Speaker: Enoch Chang, MD - MD Anderson Cancer Center, Houston

02:30pm - 03:45pm PT

Phased Relief: Optimizing Dose for Bilateral Trigeminal Neuralgia Radiosurgery

Speaker: Vangipuram Shankar, MD, MBBS - Apollo Proton Cancer Centre, Chennai

02:30pm - 03:45pm PT

Piloting the Role of an Advanced Practice Radiation Therapist to Relieve Stress on Radiation Oncologists, Increase Productivity, and Improve Care for Patients Needing Urgent Palliative Radiation

Speaker: Danielle McDonagh, DSc, MS, RT - Mount Sinai Hospital, New York

02:30pm - 03:45pm PT

PIVKA-II as an Adjunct Biomarker to AFP for the Assessment of the Early Radiographic Treatment Response to SBRT in HCC

Speaker: Srinjoy Sil, MD, PhD - NYU Langone Medical Center, New York

02:30pm - 03:45pm PT

PLDR Chemoradiation for Esophageal and Lung Cancer is Associated with Low Rates of Severe Esophagitis

Speaker: Joshua Meyer, MD, FASTRO - Fox Chase Cancer Center, Philadelphia

02:30pm - 03:45pm PT

Individualized Pancreatic Cancer Prevention: A Machine Learning Approach Integrating Polygenic Risk Scores for Absolute Risk Prediction in UK Biobank and Community Settings

Speaker: Te-Min Ke, MD, PhD - Chi Mei Medical Center, Yungkang City 701 44

02:30pm - 03:45pm PT

Predicting Pathologic Complete Response following Clinical Complete Response in Esophageal Carcinoma

Speaker: Mihir Karande, MD - Fox Chase Cancer Center, Philadelphia

02:30pm - 03:45pm PT

Predictors of Pathologic and Radiologic Response in Patients with HCC Treated with SBRT Prior to Transplant

Speaker: Evrosina Isaac, MD - Virginia Commonwealth University Health System, Richmond

02:30pm - 03:45pm PT

Pre-Treatment Cardiovascular Risk Profile in Esophageal Cancer Patients: A Comparative Analysis with Other Thoracic Malignancies

Speaker: Akinori Takada, MD, PhD - Mie university, Tsu

02:30pm - 03:45pm PT

Prognostic Predictive Role of Short-Term Efficacy Indicators in Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer

Speaker: Ningyu Wang, MD - Cancer center of China, Beijing

02:30pm - 03:45pm PT

Proton Radiotherapy Alone vs. Combined with Immuno-Oncology Agents (Proton-IO) or Tyrosine Kinase Inhibitors (Proton-TKI) for Intermediate to Advanced-Stage Hepatocellular Carcinoma

Speaker: Rodney Cheng-En Hsieh, MD, PhD - Chang Gung Memorial Hospital Linkou Branch, Taoyuan City

02:30pm - 03:45pm PT

PSMA-PET Guided Metastasis-Directed Therapy

Speaker: Elitza Koutleva, MD, MBA - University of North Carolina at Chapel Hill, Chapel Hill

02:30pm - 03:45pm PT

Quality of Life Assessment of Palliative Radiotherapy for Patients with Low-Risk Asymptomatic Bone Metastasis: A Prospective Observational Study

Speaker: Yutaro Koide, MD, PhD - Aichi Cancer Center Hospital, Nagoya

02:30pm - 03:45pm PT

Radiation Therapy for Cancer Pain with and without a Neuropathic Component: A Single-Center Prospective Observational Study

Speaker: Kohsei Yamaguchi, MD, PhD - Ariake medical center, Arao

02:30pm - 03:45pm PT

Radiosurgery Outcomes in Pure Venous Conflict Trigeminal Neuralgia Efficacy, Safety, and Long-term Outcomes

Speaker: Vangipuram Shankar, MD, MBBS - Apollo Proton Cancer Centre, Chennai

02:30pm - 03:45pm PT

Radiotherapy as an Organ-Preserving Alternative to Surgery in Patients with Locally Advanced Esophageal Squamous Cell Carcinoma Achieving Major Pathologic Response after Induction Immunochemotherapy

Speaker: Xin-Yun Song, MD - Shanghai Chest Hospital, Shanghai

02:30pm - 03:45pm PT

Radiotherapy Combined with Systemic Therapy vs. Systemic Therapy Alone for Recurrent or Metastatic Esophageal Cancer: A Systematic Review and Meta-Analysis

Speaker: Jun Wang, MD, PhD - Fourth Hospital of Hebei Medical University, Shijiazhuang

02:30pm - 03:45pm PT

Radiotherapy of Dupuytren's Contracture Following Collagenase Treatment

Speaker: Colton Cox, BS - University of Nevada Reno School of Medicine, Reno

02:30pm - 03:45pm PT

Radiotherapy-Boosted Thymosin Alpha-1 Based Immunotherapy: A Cutting-Edge Approach to Amplifying Immune Dynamics and Therapeutic Efficacy in Advanced Solid Tumors

Speaker: Yuehong Kong, - The Second Affiliated Hospital of Soochow University, ???

02:30pm - 03:45pm PT

Rapid Response Palliative Radiotherapy Program (RAPRT): Experience with a Non-Classical Model

Speaker: Isidora King, MD - Clinica IRAM, Santiago

02:30pm - 03:45pm PT

Reduced Time to Start with Radiotherapy Treatment Using Online Adaptive Radiotherapy without Planning CT Scan: A Prospective Clinical Trial in Patients with Rectal Cancer

Speaker: Claudia Schuurhuizen, MD, PhD - Erasmus Medical Center, Rotterdam

02:30pm - 03:45pm PT

Reirradiation for Abdominal GastroIntestinal Malignancies: A Systematic Review by the Reirradiation Collaborative Group (ReCOG)

Speaker: Nauman Malik, MD, MS - Princess Margaret Cancer Centre, Toronto

02:30pm - 03:45pm PT

Reirradiation with SBRT in Radiorecurrent Prostate Cancer ? Impact on Disease Control and Quality of Life Outcomes

Speaker: Papaiah Susheela Sridhar, MD, DNB - Apollo Cancer centre,Bangalore, Bangalore

02:30pm - 03:45pm PT

Relationship of PD-L1 Status and Outcomes in a Diverse Patient Population with Anal Squamous Cell Carcinoma

Speaker: Daniel Cherry, MD, MAS - Mount Sinai Hospital, New York

02:30pm - 03:45pm PT

Risk Factors for Lateral Pelvic Lymph Node Metastasis in Rectal Cancer

Speaker: Özge Duran Can, MD - Celal Bayar University, Faculty of Medicine, Department of Radiation Oncology, Manisa

02:30pm - 03:45pm PT

Risk of Vertebral Compression Fractures after Hypofractionated Spine Stereotactic Body Radiation Therapy

Speaker: Zhen Li, - Zhongshan People's Hospital, Zhongshan

02:30pm - 03:45pm PT

Role of Intraoperative Radiotherapy in Hepatocellular Carcinoma Following Narrow-Margin Hepatectomy: A Single Institutional Long-Term Follow Up Analysis

Speaker: Mengyuan Li, MD - National Cancer Center/National Clinical Research Center for Cancer Cancer Hospital, CAMS & PUMC, Beijing

02:30pm - 03:45pm PT

Sacral and Other Pelvic Bone Fractures Following Short-Course Radiation Therapy and Consolidation Chemotherapy for Rectal Cancer

Speaker: Panos Papanikolaou, MD - Johns Hopkins Hospital, Baltimore

02:30pm - 03:45pm PT

Safe Delivery of Ablative, Non-Adaptive Pancreas and Elective Nodal RT in Borderline Resectable and Locally Advanced Pancreatic Cancer

Speaker: Reine Abou Zeidane, MD - University Hospitals Seidman Cancer Center | Case Western Reserve University, Cleveland

02:30pm - 03:45pm PT

Short-Course Radiotherapy, Chemotherapy and Surgery in Rectal Cancer Patients under 50: Recurrence and Survival Outcomes

Speaker: David Simson, MBBS, DNB - Rajiv Gandhi Cancer Institute & Research Centre, New Delhi

02:30pm - 03:45pm PT

Simulation-Free Single-Fraction Conventional and Stereotactic Radiotherapy for Bone and Soft Tissue Metastases

Speaker: Joanna Javor, MS, CMD, RT - UHN, Toronto

02:30pm - 03:45pm PT

Stereotactic Ablative MR-Guided Online Adaptive Radiation Therapy (SMART) for Management of Borderline Resectable and Locally Advanced Pancreatic Carcinoma

Speaker: Neris Dincer, MD - Acibadem Universitesi, Istanbul

02:30pm - 03:45pm PT

Stereotactic Body Radiation Therapy for Adrenal Metastases: Evaluation of Efficacy and Toxicity Outcomes.

Speaker: Mohammad Alsmairat, MD - King Hussein Cancer Center, Amman

02:30pm - 03:45pm PT

Stereotactic Body Radiation Therapy for Ventricular Tachycardia is Safe and Effective: Results from a Large Retrospective Cohort

Speaker: Keith Cengel, MD, PhD - University of Pennsylvania, Philadelphia

02:30pm - 03:45pm PT

Stereotactic Body Radiation Therapy (SBRT) for Hepatocellular Carcinoma (HCC) with and without Liver Transplant in Patients with Advanced Hepatic Cirrhosis.

Speaker: Parisa Shamsesfandabadi, MD - Duke University Medical Center, Durham

02:30pm - 03:45pm PT

Stereotactic Body Radiation Therapy (SBRT) vs. Irreversible Electroporation (IRE) in the Treatment of Locally Advanced Pancreatic Cancer, A Systematic Review and Meta-Analysis Comparing Median Overall Survival and Severe Adverse Events

Speaker: Deniz Demircioglu, BS - Medical College of Wisconsin, Milwaukee

02:30pm - 03:45pm PT

Stereotactic Body Radiation Therapy with PD-1 Inhibitor for Locally Advanced or Locoregionally Recurrent Pancreatic Cancer (preSPARK-1 Study)

Speaker: Yi Chen, MD - Peking University Third Hospital, Beijing

02:30pm - 03:45pm PT

Stereotactic Body Radiotherapy for Osseous Low Alpha-Beta Resistant Metastases for Pain Relief - SOLAR-P

Speaker: Stephan Tran, MD, BS, MBS - Sunnybrook Odette Cancer Centre, Toronto

02:30pm - 03:45pm PT

Stereotactic Body Radiotherapy (SBRT) in the Treatment of Oligometastatic Breast Cancer: A Multi-Institutional Feasibility Trial

Speaker: Elysia Donovan, MD, MS - Juravinski Cancer Centre, Hamilton

02:30pm - 03:45pm PT

Stereotactic Radioablation to Ventricular Tachycardia: Prospective Phase I Study in Asian Country

Speaker: Mariko Kawamura, MD, PhD - Nagoya University hospital, Nagoya

02:30pm - 03:45pm PT

Study of Relationship between Proton Beam Therapy to Liver Cancers and Persistent Pleural Effusion

Speaker: Sae Matsumoto, MD - Fukui Prefecture Hospital, Fukui 910-8526

02:30pm - 03:45pm PT

Surgical Outcomes in Locally Advanced Rectal Cancer Following Preoperative Chemoradiation with Simultaneous Integrated Boost (SIB-CRT)

Speaker: Mauro Loi, MD, PhD - Azienda Ospedaliera Universitaria Careggi, Florence

02:30pm - 03:45pm PT

Systemic Therapy with or without Local Radiotherapy for Advanced Esophageal Carcinoma: A Systematic Review and Meta-analysis

Speaker: Xiaoxi Chen, - Department of Radiation Oncology, The Fourth Hospital of Hebei Medical University, Shijiazhuang

02:30pm - 03:45pm PT

The Impact of Immunotherapy on Splenomegaly and Thrombocytopenia in Locally Advanced Rectal Cancer Patients Undergoing Total Neoadjuvant Therapy

Speaker: Yaqi Wang, MD - Fudan University Shanghai Cancer Center, Shanghai

02:30pm - 03:45pm PT

The Impact of Tumor-Induced Nutritional Disorders on the Relationship between G8 Scores and Definitive Radiotherapy Strategies

Speaker: Ikuno Nishibuchi, MD, PhD - Department of Radiation Oncology, Hiroshima University, Hiroshima

02:30pm - 03:45pm PT

The Importance of Lymphopenia Severity in Anal Cancer Patients Undergoing Definitive Therapy

Speaker: Dulguun Myagmarsuren, BS - Virginia Tech Carilion School of Medicine, Roanoke

02:30pm - 03:45pm PT

The Predictive Value of Pretreatment Peripheral T-Lymphocyte Subsets for Therapeutic Efficacy in Esophageal Squamous Cell Carcinoma Patients Undergoing Neoadjuvant Chemoradiotherapy: A Prospective Cohort Analysis

Speaker: Wei-Xiang Qi, MD, RT - Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai

02:30pm - 03:45pm PT

The Relationship between Liver Metastasis Shrinkage Rate and Quantitative Values in Lu-177 DOTATATE Therapy for Somatostatin Receptor-Positive Neuroendocrine Tumors

Speaker: Kenta Konishi, MD, PhD - Hamamatsu University School of Medicine, Hamamatsu

02:30pm - 03:45pm PT

Time-Dependent Toxicity Modeling and Local Control in BID Thoracic Reirradiation: Implications for Personalized Radiotherapy

Speaker: Cecilia de Sousa, MD, MPH - Johns Hopkins Medicine, Baltimore

02:30pm - 03:45pm PT

To Explore the Efficacy and Safety of Neoadjuvant Chemoradiotherapy in Locally Advanced Colon Cancer: A Systematic Review and Meta-Analysis

Speaker: Jingyi Sun, RT - The Fourth Hospital of Hebei Medical University, Shijiazhuang

02:30pm - 03:45pm PT

Tracing the Pain Circuits: FCD as a Biomarker for Radiosurgery in Trigeminal Neuralgia

Speaker: Vangipuram Shankar, MD, MBBS - Apollo Proton Cancer Centre, Chennai

02:30pm - 03:45pm PT

Treatment Patterns and Outcomes in Elderly Patients with Cholangiocarcinoma

Speaker: Jino Park, MD - University of California Irvine, Orange

02:30pm - 03:45pm PT

Using an Auto-Planned VMAT-TBI Technique for Myeloablative Autologous Hematopoietic Stem Cell Transplantation for Scleroderma (the STAT-2 Trial)

Speaker: Nataliya Kovalchuk, PhD - Stanford University School of Medicine, Palo Alto

02:30pm - 03:45pm PT

Utility of Screening for Oligometastatic Disease: A Systematic Review

Speaker: Alysa Fairchild, MD - Cross Cancer Institute, Edmonton

02:30pm - 03:45pm PT

Utilization of 4D-CBCT in lieu of Intra-Hepatic Fiducial Markers for Tumor Localization in Liver SBRT - Description of a Novel Technique and Clinical Outcomes in a Retrospective Cohort

Speaker: Jacob Oyeniyi, MD - Corewell Health William Beaumont University Hospital, Royal Oak

02:30pm - 03:45pm PT

PQA 08 - Gastrointestinal Cancer, Nonmalignant Disease, Palliative Care

session DESCRIPTION

Presentations

10-year Experience of Ultra-Hypofractionated SBRT for Adrenal Metastases

3-Dimensional Treatment Planning and Target Volume Definition of Osteoarthritis - Recommendations of the International Benign Target Volume Peer Group

A Large Animal Study of a Novel Cardiac-Ultrasound Image Guidance for Cardio-Respiratory-Gated Radiation Ablation to Ventricular Tachycardia Targets Using Proton Therapy

A Longitudinal CT-Based Subregional Radiomics Nomogram for Predicting Local Recurrence-Free Survival in Esophageal Squamous Cell Carcinoma Treated with Definitive Chemoradiotherapy: A Multicenter Study

A Machine Learning Model Based on Computed Tomography Radiomics for the Prediction of the Response to SBRT in Lung Metastasis from Colorectal Cancer

A Multi-Dimensional Deep Ensemble Learning Model Predicts Pathological Response and Treatment Outcomes to Neoadjuvant Chemoradiotherapy in Esophageal Squamous Cell Carcinoma Using Pretreatment CT Images: A Multicenter, Retrospective Cohort Study

A Preliminary Investigation into the Clinical Application of Magnetic Resonance Linear Accelerator for Treating Hepatocellular Carcinoma and Colorectal Cancer Liver Metastasis

A Prospective Study of CT-Guided and 3D-Printing Template-Assisted Implantation of Fiducial Markers in the Pancreatic Carcinoma for Stereotactic Body Radiation Therapy (FIRST-1 Study)

Ablative Radiotherapy for Inoperable Non-Metastatic Pancreatic Cancer: Long-Term Results in a Single Center

Achievable Dosimetry for the Anterior Vaginal Wall and Bulboclitorus with Vaginal Dilator Use in Pelvic Radiotherapy for Anal and Rectal Cancers

Analysis of Treatment Patterns and Prognostic Factors in Patients with Esophageal Fistula after Radiotherapy for Esophageal Squamous Cell Carcinoma

Analysis of Urgent Starts for Radiotherapy that Occur on Weekends at an Academic Institution

Association of Central Hepatobiliary Tract Radiation Dose and Hepatobiliary Outcomes after MRI-Guided Liver Stereotactic Body Radiotherapy

Association of Skeletal Muscle and Adiposity Measured by Computed Tomography with Toxicity and pCR in Esophageal Squamous Cell Carcinoma Receiving Standardized Neoadjuvant Chemoradiotherapy

Barriers and Facilitators to Anal Cancer Screening and Treatment for Patients with HIV: Physician Perceptions and Practices

Bone Marrow-Sparing Radiotherapy could Limit or Avoid Radiation Induced Lymphopenia and Thrombocytopenia in Esophageal Cancer Patients after Neoadjuvant Chemoradiotherapy

Breaking the Stigma: Oncology Providers Weigh in on Psychedelic-Assisted Therapy

Carbon-Ion Radiotherapy for Elderly Patients with Locally Advanced Pancreatic Cancer

Cardiomyocytes Upregulated the PD-L1 Expression to Alleviate Cardiac Injury Induced by Irradiation Combined with Anti-PD-1 Antibody: An In Vitro and In Vivo Study

Changes in Apparent Diffusion Coefficient After Radiation Therapy for Bone Metastases: A Comparative Study of SBRT and Conventional RT

Chronotherapeutic Effects of Immune Checkpoint Inhibitors and Stereotactic Body Radiotherapy: Secondary Analysis of a Prospective Trial

Circulating Tumor DNA Dynamics as Prognostic Biomarkers in Esophageal Squamous Cell Carcinoma (ESCC) Receiving Definitive Radiotherapy: A Prospective Cohort Study

Cistern-Guided Radiosurgery: Personalized Dose Adaptation for Young Medically Refractory Trigeminal Neuralgia Patients

Clinical and Dosimetric Predictors for Radiation-Induced Acute Upper Gastrointestinal Bleeding in Patients with Hepatocellular Carcinoma Undergoing Proton or Photon Radiation Therapy

Clinical Application of Simultaneous Integrated Boost in Stereotactic Body Radiotherapy for Large-Volume Tumors: A Single-Center Retrospective Study

Clinical Benefit of Adding Irinotecan to Standard Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer: A Systematic Review and Meta-Analysis

Clinical Benefits of Postoperative Adjuvant Immunotherapy for Resectable Locally Advanced Esophageal Cancer

Clinical Considerations of Splenic Dose Constraints to Mitigate Radiation-Induced Lymphopenia

Clinical Outcomes and Patterns of Failures of Patients with Oligometastatic Anal Squamous Cell Carcinoma Treated with Definitive-Intent Chemoradiation and Metastasis-Directed Therapy

Clinical Outcomes and Safety of the Combination of External Beam Radiotherapy with <sup>177</sup>Lu-DOTATATE

Clinical Outcomes of SBRT for Oligometastatic Bone Disease and the Risk Factor of Local Recurrence

Combining Lu177-PSMA and External Beam Radiation Therapy: A Retrospective Safety Analysis

Treatment Outcomes and Prognostic Factors in Young-Onset Rectal Cancer

Comparative Effectiveness of Neoadjuvant Chemoradiotherapy vs. Chemoimmunotherapy in Locally Advanced Resectable Esophageal Squamous Cell Carcinoma: A Multicenter Real-World Study

Comparative Evaluation of Quality of Life with EORTC-CR29 QoL Questionnaire between Nonoperative Management and Surgical Patients Following Total Neoadjuvant Treatment in Locally Advanced Rectal Cancer

Comparing Stereotactic Body Radiation Therapy and Hypofractionated Radiation for Unresectable Intrahepatic and Perihilar Cholangiocarcinoma: A Retrospective Analysis

Correlation between Adverse Events Therapeutic Response and Microbiome Changes

Correlation between Pan-Immune Inflammation Value Dynamics and Magnetic Resonance Imaging Response in Locally Advanced Rectal Cancer Treated with Total Neoadjuvant Therapy

Cost-Effectiveness of Comprehensive Metastasis Directed Therapy in Patients with Oligometastatic Pancreatic Ductal Adenocarcinoma

CoVART: A Retrospective Cohort Study of Conventionally Fractionated RT vs. Ablative RT Dosing in the Treatment of Locally Advanced Pancreatic Cancer

CT-Based Target Delineation and Low-Dose Radiotherapy for Knee Osteoarthritis - A Single Center Experience

Deep and Durable Prostate-Specific Antigen Response Following Comprehensive Involved Site Radiotherapy for Prostate Cancer Oligometastases

A CRM-Integrated ypT Staging System Improves Prognostic Stratification Following Neoadjuvant Therapy in Rectal Cancer

Development and Analysis of a Nomogram Based on Prognostic Factors in Locally Advanced Esophagogastric Junction Adenocarcinoma Treated with Neoadjuvant Chemoradiotherapy

Development and Evaluation of a Protocol for Managing Hyperkalemia in Patients with Metastatic Neuroendocrine Tumor Treated with Radiopharmaceuticals

Development and Validation of a Predictive Nomogram for Abdominal Lymph Node Recurrence in Patients with Thoracic Esophageal Squamous Cell Carcinoma: Insights from a Multicenter Study

Differential Dose-Volume Indices-Based Machine Learning Model for Severe Radiation-Induced Lymphopenia in Patients with Upper Abdominal Malignancies

Does Thoracic Radiotherapy Combined with Immune Checkpoint Inhibitors Increase Cardiac Toxicity? — A Systemic Review and Meta-Analysis

Dose Accumulation and Geometric Variation of Local Recurrence in Anal Cancer Patients Receiving Concurrent Chemoradiation

Dose-Volume Constraints Associated with Liver Toxicity in Patients with Small Livers Receiving Liver Stereotactic Body Radiation Therapy

Dosimetric Comparison of Carbon Ion Beam Therapy and SBRT for Ventricular Arrhythmia

Durable Clinical Response Following Radiosurgery for Trigeminal Neuralgia is Predicted by Volumetric Dose Distribution to the Cisternal Portion of the Nerve

Durable Local Control of Adding Palliative Radiotherapy to Nivolumab for Advanced Esophageal Cancer

Early Clinical Results of Spatially Fractionated Radiation Therapy (SFRT) with GRID in the Treatment of Bulky/Advanced Tumors

Early Outcomes of Dose-Escalated Radiation Therapy for Pancreatic Cancer

Effect of Prophylactic Thrombopoietin and Magnetic Resonance Guided Bone Marrow-Sparing Concurrent Chemoradiotherapy on Thrombocytopenia for Thoracic Esophageal Cancer: Final Analysis of a Phase II Study

Effect of Same-Day Volumetric Modulated Arc Therapy on Resource Utilization in Rapid Access Palliative Radiotherapy Clinics Using a Radiation Oncologist-Initiated Automated Planning Script

Efficacy and Safety of Neoadjuvant Therapies in Locally Advanced Esophageal Squamous Cell Carcinoma: A Comprehensive Retrospective Analysis

Efficacy and Safety of Stereotactic Intensity-Modulated Proton Therapy (SIMPT) in Unresectable Hepatocellular Carcinoma

Stereotactic Body Radiation Therapy (SBRT) to Sites of Oligoprogression during Lutetium-177-PSMA-617 (Lu-PSMA) Treatment for Metastatic Castrate Resistant Prostate Cancer

Trends in Local Therapy for Hepatocellular Carcinoma from 2004-2019: An NCDB Analysis

Ending the HIV Epidemic with Low Dose Total Body Irradiation in Combination with Anti-Microtubule Therapy

Endobronchial HDR Brachytherapy for Post-Transplant or Wegener's Granulomatosis Associated Bronchial Stenosis: Extended Follow-up of Pulmonary Function, Subsequent Procedures, and Second Malignancy

Escalated-Dose Ablative Radiation Therapy for Oligometastatic Pancreatic Cancer: A Single-Institution Experience

Evaluating KPIs in Palliative Care: Insights from a Tertiary Center

Evaluation of Short-Term Efficacy and Long-Term Prognostic Factors following Neoadjuvant Chemoradiotherapy in Patients with Locally Advanced Rectal Cancer

Exercise Enhancement after Radiotherapy for Bone Metastases: A Phase I Feasibility Trial for Patients with Painful Non-Spine Bone Metastases (EXERT-BM)

Exploratory Analysis of PET and CA 19-9 Response in Pancreatic Ductal Adenocarcinoma Outcomes: A Secondary Analysis of a Prospective Phase 2 Trial

Extended-Field Definitive Chemoradiation for Patients with Anal Squamous Cell Carcinoma with Nodal Metastatic Disease

External Beam Radiotherapy (EBRT) + Immunotherapy (IO) in the Management of Hepatobiliary Malignancies: A Meta-Analysis of Treatment Response Rates

FAP-Targeted PET/CT with [18F]AlF-NOTA-FAPI-04 in Hepatocellular Carcinoma: Prospective Correlation of Fibrosis Quantification with Treatment Response and Survival Outcomes

Feasibility and Safety of Black Soybean Extract Cream on Radiation-Induced Dermatitis, Pain and Quality of Life in Head and Neck Cancer Patients: A Phase I, Single-Arm, Open-Label Prospective Study

Feasibility of 3 Fraction Treatment Using Stereotactic Magnetic Resonance - Guided Adaptive Radiation Therapy in Single or Three Fractions for Oligometastases in the Abdomen and Pelvis: Results from the Phase I SMART-STOP 3-Fraction Cohort

Feasibility of Serial Tumor-Informed ctDNA Testing to Assess Response to Chemoradiation in Esophageal Cancer

Four-Year Results of a Phase I/II Single-Arm Prospective Clinical Trial of Stereotactic Magnetic Resonance Guided Adaptive Radiation Therapy (SMART) for Metachronous Oligometastatic Abdominopelvic Lymph Node and Soft Tissue Metastases

Fractionated Stereotactic Radiotherapy in People with Drug-Resistant Focal Epilepsy: First-In-Human Experience with a Healthy Tissue-Preserving Dose-Fractionation Concept

A Non-Invasive Stereotactic Mimicking Radiosurgery with a Frameless Robotic Radiosurgery: A Comparison of Dose Prescription Methodologies for Treatment of Trigeminal Neuralgia